The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

BACKGROUND: There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) re...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:RMD Open
Glavni autori: Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2015
Teme:
Rheumatoid Arthritis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://ncbi.nlm.nih.gov/pubmed/26509062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000040
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items